Absorbed dose estimates for 131I-labelled monoclonal antibody therapy in patients with intraperitoneal pseudomyxoma
暂无分享,去创建一个
[1] P. Sugarbaker. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. , 1989, Canadian journal of surgery. Journal canadien de chirurgie.
[2] P. Nuttall. Methods of Assessment of Absorbed Dose in Clinical Uses of Radionuclides , 1981 .
[3] G J Hademenos,et al. Comparison of four scatter correction methods using Monte Carlo simulated source distributions. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] C S Chui,et al. Radionuclide photon dose kernels for internal emitter dosimetry. , 1996, Medical physics.
[5] R. Berkowitz,et al. Pseudomyxoma Peritonei: A Review of 23 Cases , 1994, Obstetrics and gynecology.
[6] K. Kairemo,et al. Radioimmunotherapy of solid cancers: A review. , 1996, Acta oncologica.
[7] M Ljungberg,et al. A Monte-Carlo program converting activity distributions to absorbed dose distributions in a radionuclide treatment planning system. , 1996, Acta oncologica.
[8] E. Mok,et al. Brachytherapy seed dose distribution calculation employing the fast Fourier transform. , 1986, Medical physics.
[9] R Mohan,et al. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] S. Savolainen,et al. Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy. , 1996, Cancer biotherapy & radiopharmaceuticals.
[11] M. Tenhunen,et al. The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma , 1997, Cancer.
[12] J. Laitinen,et al. SPECT-based radioimmunotherapy planning system , 1997, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 'Magnificent Milestones and Emerging Opportunities in Medical Engineering' (Cat. No.97CH36136).
[13] C. Mulhern,et al. External imaging techniques for quantitation of distribution of I-131 F(ab')2 fragments of monoclonal antibody in humans. , 1984, Medical physics.
[14] E E Watson,et al. A model of the peritoneal cavity for use in internal dosimetry. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] Kenneth F. Koral,et al. Preliminary results from intensity‐based CT‐SPECT fusion in I‐131 anti‐B1 monoclonal‐antibody therapy of lymphoma , 1997, Cancer.
[16] J. Siegel,et al. MIRD formulation. , 1993, Medical physics.
[17] E. Yorke,et al. Treatment planning for radio-immunotherapy. , 1996, Physics in medicine and biology.
[18] R L Wahl,et al. CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] R Mohan,et al. Three-dimensional dosimetry for radioimmunotherapy treatment planning. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] C S Chui,et al. A Monte Carlo approach to patient-specific dosimetry. , 1996, Medical physics.
[21] Murray H. Loew,et al. Use of the fast Hartley transform for efficient 3D convolution in calculation of radiation dose , 1994, Proceedings of 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[22] D A Podoloff,et al. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J. Schlom,et al. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients. , 1995, Anticancer research.
[24] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[25] D. Podoloff,et al. Improved conjugate view quantitation of I-131 by subtraction of scatter and septal penetration events with a triple energy window method. , 1995, Medical physics.
[26] A L Boyer,et al. Validation of a dose-point kernel convolution technique for internal dosimetry , 1995, Physics in medicine and biology.